Ying Liu, MS. Co-Founder and President
Ms. Liu has more than20 years industry experience. She was formerly Sr. Manager of In Vivo Pharmacology at Intradigm Corporation/Silence Therapeutics; Before that, she held positions at Abgenix/Amgen, and DNAX/Schering Plough Biopharma. Ms. Liu has a strong expertise in immunology, oncology, molecular and cell biology, assay development, antibody target validation, antibody characterization, HTP siRNA screening, and in vivo animal models. She contributed to one FDA approved drug, more than 10 publications, and more than 10 granted/pending patent applications